533 related articles for article (PubMed ID: 32845813)
1. The Role of Visceral Adiposity Index as Predictor of Metabolic Syndrome in Obese and Nonobese Women with Polycystic Ovary Syndrome.
de Medeiros SF; de Medeiros MAS; Barbosa BB; Yamamoto MMW
Metab Syndr Relat Disord; 2021 Feb; 19(1):18-25. PubMed ID: 32845813
[No Abstract] [Full Text] [Related]
2. Comparison of metabolic and obesity biomarkers between adolescent and adult women with polycystic ovary syndrome.
de Medeiros SF; de Medeiros MAS; Barbosa BB; Yamamoto MMW; Maciel GAR
Arch Gynecol Obstet; 2021 Mar; 303(3):739-749. PubMed ID: 33201375
[TBL] [Abstract][Full Text] [Related]
3. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.
Durmus U; Duran C; Ecirli S
J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of a new anthropometric indicator - VAI (Visceral Adiposity Index) in the evaluation of metabolic and hormonal disorders in women with polycystic ovary syndrome.
Brończyk-Puzoń A; Jagielski P; Kulik-Kupka K; Koszowska A; Nowak J; Zubelewicz-Szkodzińska B
Adv Clin Exp Med; 2017 Aug; 26(5):825-828. PubMed ID: 29068579
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of polycystic ovary syndrome in Chinese obese women of reproductive age with or without metabolic syndrome.
Liang P; Xi L; Shi J; Li W; Zhao S; Deng Y; Wang R; Sun Y; Gu B; Yuan L; Zhang Y; Gu W; Wang W; Hong J
Fertil Steril; 2017 Apr; 107(4):1048-1054. PubMed ID: 28238496
[TBL] [Abstract][Full Text] [Related]
6. A visceral adiposity index-related dietary pattern and the cardiometabolic profiles in women with polycystic ovary syndrome.
Ehsani B; Moslehi N; Mirmiran P; Ramezani Tehrani F; Tahmasebinejad Z; Azizi F
Clin Nutr; 2016 Oct; 35(5):1181-7. PubMed ID: 26699405
[TBL] [Abstract][Full Text] [Related]
7. The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome.
Anik Ilhan G; Yildizhan B; Pekin T
Gynecol Endocrinol; 2019 Mar; 35(3):233-236. PubMed ID: 30303693
[TBL] [Abstract][Full Text] [Related]
8. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
Graff SK; Mário FM; Alves BC; Spritzer PM
Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
[TBL] [Abstract][Full Text] [Related]
9. Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women.
Mokhlesi B; Scoccia B; Mazzone T; Sam S
Fertil Steril; 2012 Mar; 97(3):786-91. PubMed ID: 22264851
[TBL] [Abstract][Full Text] [Related]
10. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
Holte J; Bergh T; Berne C; Lithell H
Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
[TBL] [Abstract][Full Text] [Related]
11. Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life.
Pinola P; Puukka K; Piltonen TT; Puurunen J; Vanky E; Sundström-Poromaa I; Stener-Victorin E; Lindén Hirschberg A; Ravn P; Skovsager Andersen M; Glintborg D; Mellembakken JR; Ruokonen A; Tapanainen JS; Morin-Papunen LC
Fertil Steril; 2017 Mar; 107(3):788-795.e2. PubMed ID: 28089571
[TBL] [Abstract][Full Text] [Related]
12. The visceral adiposity index as a predictor of insulin resistance in young women with polycystic ovary syndrome.
Oh JY; Sung YA; Lee HJ
Obesity (Silver Spring); 2013 Aug; 21(8):1690-4. PubMed ID: 23585246
[TBL] [Abstract][Full Text] [Related]
13. Indirect Predictors of Visceral Adipose Tissue in Women with Polycystic Ovary Syndrome: A Comparison of Methods.
Kałużna M; Czlapka-Matyasik M; Bykowska-Derda A; Moczko J; Ruchala M; Ziemnicka K
Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444654
[TBL] [Abstract][Full Text] [Related]
14. Metabolic profile in women with polycystic ovary syndrome across adult life.
Echiburú B; Crisosto N; Maliqueo M; Pérez-Bravo F; de Guevara AL; Hernández P; Cavada G; Rivas C; Clavel A; Sir-Petermann T
Metabolism; 2016 May; 65(5):776-782. PubMed ID: 27085784
[TBL] [Abstract][Full Text] [Related]
15. Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as Markers of Insulin Resistance and Metabolic Associated Disturbances in Young Argentine Women with Polycystic Ovary Syndrome.
Abruzzese GA; Cerrrone GE; Gamez JM; Graffigna MN; Belli S; Lioy G; Mormandi E; Otero P; Levalle OA; Motta AB
Horm Metab Res; 2017 Jan; 49(1):23-29. PubMed ID: 27571188
[TBL] [Abstract][Full Text] [Related]
16. Association between visceral adiposity index, hirsutism and cardiometabolic risk factors in women with polycystic ovarian syndrome: A cross-sectional study.
Fonseka S; Subhani B; Wijeyaratne CN; Gawarammana IB; Kalupahana NS; Ratnatunga N; Rosairo S; Vithane KP
Ceylon Med J; 2019 Sep; 64(3):111-117. PubMed ID: 32120461
[TBL] [Abstract][Full Text] [Related]
17. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
[TBL] [Abstract][Full Text] [Related]
18. Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls.
Glintborg D; Petersen MH; Ravn P; Hermann AP; Andersen M
Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1235-1243. PubMed ID: 27529295
[TBL] [Abstract][Full Text] [Related]
19. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome.
Rajkhowa M; Neary RH; Kumpatla P; Game FL; Jones PW; Obhrai MS; Clayton RN
J Clin Endocrinol Metab; 1997 Oct; 82(10):3389-94. PubMed ID: 9329374
[TBL] [Abstract][Full Text] [Related]
20. Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment.
Amato MC; Guarnotta V; Forti D; Donatelli M; Dolcimascolo S; Giordano C
Hum Reprod; 2013 Jul; 28(7):1919-28. PubMed ID: 23592224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
